Nigella sativa Supplementation Improves Asthma Control and Biomarkers: A Randomized, Double-Blind, Placebo-Controlled Trial
Koshak A, Wei L, Koshak E, Wali S, Alamoudi O
Published in Phytotherapy Research
Methodology
Randomized, double-blind, placebo-controlled trial of Nigella sativa oil 500 mg twice daily for 4 weeks as add-on asthma therapy (NCT02407262).
Key Findings
Asthma Control Test scores improved versus placebo, with reductions in blood eosinophils; pulmonary function changes were limited.
Conclusions
Nigella sativa oil improved asthma control and some inflammatory biomarkers as supplementary treatment.
Limitations
Short 4-week duration, 25% dropout, single centre, modest sample.
Supplements Studied
NSO capsules 500 mg twice daily for 4 weeks were used as a supplementary treatment in a randomized, double-blind, placebo-controlled trial in asthmatics
Related Health Concerns
Study Details
Access Study
Disclosures
Funding
Not reported
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.